June 28, 2017

Platform Technology

Three Components of MangoGen’s Patented Platform Technology

  1.  Insertion of human gene(s) in to a baculovirus.
  2.  Protection from serum inactivation by encapsulation
  3.  Coating onto a suitable matrix, or formulated into a cream/gel

Schematic illustrating MangoGen’s Technology applied to a cardiac stent

MangoGen is developing the following:

  1. New generation of gene-delivering cardiac stents
  2. Gene-delivering cream/gel to accelerate open wound healing (e.g. diabetic foot ulcers, surgery, wound repair)
  3. Gene-delivering sutures to prevent scar tissue formation